Kardigan's IPO
Listed Jun 18, 2026 at $16 on Nasdaq as KARD. Today 28% below its $16 offer price; its first day closed +37.5%.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
What does Kardigan do?
| Fact | Kardigan |
|---|---|
| What it does | “Kardigan is a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist.” |
| Founded | 2023 |
| Incorporated | Delaware, 2023 |
| Headquarters | Princeton, New Jersey |
| Employees | 241 full-time, as of March 31, 2026 |
| Website | kardigan.bio |
What is the offering?
Each figure names the filing it is from and that filing's date. The market cap is Breakaway's arithmetic from the prospectus's share count.
| Fact | Kardigan |
|---|---|
| Shares offered | 25,000,000 |
| Offer price | $16 a share |
| Raised at that price | $400 million |
| Underwriters' discount | $28 million |
| Net proceeds the company expects | About $367 million |
| Underwriters' option | 3,750,000 more shares |
| Underwriters | J.P. Morgan, Jefferies, Leerink Partners, and TD Cowen |
| Exchange | Nasdaq Global Market, as KARD |
| Shares outstanding after | 89,339,121 |
| Market cap at the offer price | $1.43 billion |
What the filing says about its money
| Fact | Kardigan |
|---|---|
| Revenue | None from product sales yet |
| Last preferred stock | Series B preferred |
| Raised before the IPO | $568 million in private financings |
What risks does Kardigan name first?
- “We are a clinical-stage biopharmaceutical company with a limited operating history, which may make it difficult to evaluate our current business and predict our future success and viability.”
- “Even if this offering is successful, we will require additional funding in order to finance our operations.”
- “Our business is highly dependent on the success of our product candidates, particularly Danicamtiv for genetic DCM, Ataciguat for moderate CAVS, and Tonlamarsen for post-hospitalization management of ASH. If we are unable to successfully complete clinical development…”
Dates so far
| What | Day |
|---|---|
| Registration filed | May 26, 2026 |
| Exchange registration filed | Jun 15, 2026 |
| Declared effective by the SEC | Jun 17, 2026 |
| Priced | Jun 17, 2026 |
| First trade | Jun 18, 2026 |
| Lock-up ends | Dec 14, 2026 |
How did its first days trade?
From its daily bars, each close against its $16 offer price.
| Day | Open | Close | From the offer |
|---|---|---|---|
| Jun 18 | $16.25 | $22 | +37.5% |
| Jun 22 | $21.29 | $22.77 | +42.3% |
| Jun 23 | $22.96 | $22.24 | +39.0% |
| Jun 24 | $21.68 | $22.03 | +37.7% |
| Jun 25 | $22.28 | $22.58 | +41.1% |
What is Kardigan's Quality Score?
The other IPOs expected
| Company | Price |
|---|---|
| Tracx Logis | $18 to $22 |
| $11 to $13 | |
| AM PM | $4 to $5 |
| $5 to $6 | |
| Jingrui Wang Pu | $6 |
| $4 to $5 |
Kardigan IPO questions
When is Kardigan's IPO?
Listed Jun 18, 2026 at $16 on Nasdaq as KARD.
What is Kardigan's IPO price?
Kardigan's IPO priced at $16 a share, per its final prospectus of Jun 18, 2026.
How many shares is Kardigan selling?
25,000,000 shares, and the underwriters may buy 3,750,000 more, per its final prospectus (424B4).
Who are the underwriters?
J.P. Morgan, Jefferies, Leerink Partners, and TD Cowen, as the prospectus's cover names them.
When does the lock-up end?
Kardigan's IPO lock-up ends Dec 14, 2026. Its final prospectus says: “180 days after the date of this prospectus.”
Does Breakaway rate Kardigan?
Kardigan has a Quality Score of -2 today. The score counts the 14 chart checks and the company's filings; a check that needs more history than a new stock has waits for it.
Can Breakaway say where Kardigan's price will go?
No. Breakaway does not say where a price will go. Every figure here is from the company's SEC filings, linked on each line.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.